A phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer

ConclusionsThe combination of fractionated radiation and weekly full dose nab-paclitaxel was safe and well-tolerated.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research